183 related articles for article (PubMed ID: 34952000)
1. Re-irradiation for recurrent high grade glioma (HGG) patients: Results of a single arm prospective phase 2 study.
Navarria P; Pessina F; Clerici E; Bellu L; Franzese C; Franzini A; Simonelli M; Bello L; Santoro A; Politi LS; D'agostino GR; Casarotti A; Fernandes B; Torri V; Scorsetti M
Radiother Oncol; 2022 Feb; 167():89-96. PubMed ID: 34952000
[TBL] [Abstract][Full Text] [Related]
2. Concurrent hyperthermia and re-irradiation for recurrent high-grade gliomas.
Heo J; Kim SH; Oh YT; Chun M; Noh OK
Neoplasma; 2017; 64(5):803-808. PubMed ID: 28592133
[TBL] [Abstract][Full Text] [Related]
3. Initial results of a phase II trial of
Breen WG; Youland RS; Giri S; Jacobson SB; Pafundi DH; Brown PD; Hunt CH; Mahajan A; Ruff MW; Kizilbash SH; Uhm JH; Routman DM; Jones JE; Brinkmann DH; Laack NN
J Neurooncol; 2022 Jul; 158(3):323-330. PubMed ID: 35583721
[TBL] [Abstract][Full Text] [Related]
4. A Retrospective Review of Re-irradiating Patients' Recurrent High-grade Gliomas.
Klobukowski L; Falkov A; Chelimo C; Fogh SE
Clin Oncol (R Coll Radiol); 2018 Sep; 30(9):563-570. PubMed ID: 29891395
[TBL] [Abstract][Full Text] [Related]
5. Radiosurgery and Stereotactic Brain Radiotherapy with Systemic Therapy in Recurrent High-Grade Gliomas: Is It Feasible? Therapeutic Strategies in Recurrent High-Grade Gliomas.
Gregucci F; Surgo A; Carbonara R; Laera L; Ciliberti MP; Gentile MA; Caliandro M; Sasso N; Bonaparte I; Fanelli V; Tortora R; Paulicelli E; Surico G; Lombardi G; Signorelli F; Fiorentino A
J Pers Med; 2022 Aug; 12(8):. PubMed ID: 36013284
[TBL] [Abstract][Full Text] [Related]
6. Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO).
Navarria P; Minniti G; Clerici E; Tomatis S; Pinzi V; Ciammella P; Galaverni M; Amelio D; Scartoni D; Scoccianti S; Krengli M; Masini L; Draghini L; Maranzano E; Borzillo V; Muto P; Ferrarese F; Fariselli L; Livi L; Pasqualetti F; Fiorentino A; Alongi F; di Monale MB; Magrini S; Scorsetti M
J Neurooncol; 2019 Mar; 142(1):59-67. PubMed ID: 30515706
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?
Palmer JD; Bhamidipati D; Song A; Eldredge-Hindy HB; Siglin J; Dan TD; Champ CE; Zhang I; Bar-Ad V; Kim L; Glass J; Evans JJ; Andrews DW; Werner-Wasik M; Shi W
J Neurooncol; 2018 Dec; 140(3):623-628. PubMed ID: 30182159
[TBL] [Abstract][Full Text] [Related]
8. High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting?
Gupta T; Maitre M; Maitre P; Goda JS; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Epari S; Sahay A; Patil V; Jalali R
Clin Transl Oncol; 2021 Jul; 23(7):1358-1367. PubMed ID: 33528810
[TBL] [Abstract][Full Text] [Related]
9. Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.
Palmer JD; Siglin J; Yamoah K; Dan T; Champ CE; Bar-Ad V; Werner-Wasik M; Evans JJ; Kim L; Glass J; Farrell C; Andrews DW; Shi W
J Neurooncol; 2015 Sep; 124(2):215-21. PubMed ID: 26024653
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of salvage fractionated re-irradiation combined with bevacizumab for recurrent high-grade gliomas that progressed after bevacizumab treatment*.
Yonezawa H; Ohno M; Igaki H; Miyakita Y; Takahashi M; Tamura Y; Shima S; Matsushita Y; Ichimura K; Narita Y
Jpn J Clin Oncol; 2021 Jul; 51(7):1028-1035. PubMed ID: 33959771
[TBL] [Abstract][Full Text] [Related]
11. Re-Irradiation for Recurrent Gliomas: Treatment Outcomes and Prognostic Factors.
Lee J; Cho J; Chang JH; Suh CO
Yonsei Med J; 2016 Jul; 57(4):824-30. PubMed ID: 27189273
[TBL] [Abstract][Full Text] [Related]
12. Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.
Arvold ND; Shi DD; Aizer AA; Norden AD; Reardon DA; Lee EQ; Nayak L; Dunn IF; Golby AJ; Johnson MD; Claus EB; Chiocca EA; Ligon KL; Wen PY; Alexander BM
J Neurooncol; 2017 Dec; 135(3):581-591. PubMed ID: 28975467
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas.
Song A; Andrews DW; Werner-Wasik M; Kim L; Glass J; Bar-Ad V; Evans JJ; Farrell CJ; Judy KD; Daskalakis C; Zhan T; Shi W
Radiother Oncol; 2019 Mar; 132():135-141. PubMed ID: 30825962
[TBL] [Abstract][Full Text] [Related]
14. Toxicity and efficacy of re-irradiation of high-grade glioma in a phase I dose- and volume escalation trial.
Møller S; Munck Af Rosenschöld P; Costa J; Law I; Poulsen HS; Engelholm SA; Engelholm S
Radiother Oncol; 2017 Nov; 125(2):223-227. PubMed ID: 29054380
[TBL] [Abstract][Full Text] [Related]
15. A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas.
Dixit KS; Sachdev S; Amidei C; Kumthekar P; Kruser TJ; Gondi V; Grimm S; Lukas RV; Nicholas MK; Chmura SJ; Fought AJ; Mehta M; Raizer JJ
J Neurooncol; 2021 Dec; 155(3):297-306. PubMed ID: 34689306
[TBL] [Abstract][Full Text] [Related]
16.
Fleischmann DF; Unterrainer M; Bartenstein P; Belka C; Albert NL; Niyazi M
J Neurooncol; 2017 Apr; 132(2):277-286. PubMed ID: 28102485
[TBL] [Abstract][Full Text] [Related]
17. Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis.
Moore-Palhares D; Chen H; Keith J; Wang M; Myrehaug S; Tseng CL; Detsky J; Perry J; Lim-Fat MJ; Heyn C; Maralani P; Lipsman N; Das S; Sahgal A; Soliman H
J Neurooncol; 2023 Jul; 163(3):541-551. PubMed ID: 37256526
[TBL] [Abstract][Full Text] [Related]
18. Survival gain with re-Op/RT for recurred high-grade gliomas depends upon risk groups.
Chun SJ; Park SH; Park CK; Kim JW; Kim TM; Choi SH; Lee ST; Kim IH
Radiother Oncol; 2018 Aug; 128(2):254-259. PubMed ID: 29937212
[TBL] [Abstract][Full Text] [Related]
19. Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK).
Combs SE; Niyazi M; Adeberg S; Bougatf N; Kaul D; Fleischmann DF; Gruen A; Fokas E; Rödel CM; Eckert F; Paulsen F; Oehlke O; Grosu AL; Seidlitz A; Lattermann A; Krause M; Baumann M; Guberina M; Stuschke M; Budach V; Belka C; Debus J; Kessel KA
Cancer Med; 2018 May; 7(5):1742-1749. PubMed ID: 29573214
[TBL] [Abstract][Full Text] [Related]
20. Narrative review of palliative hypofractionated radiotherapy for high grade glioma.
Saeed H; Tseng YD; Lo SS
Ann Palliat Med; 2021 Jan; 10(1):846-862. PubMed ID: 33040565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]